Presentation is loading. Please wait.

Presentation is loading. Please wait.

Cancer Diagnostics Market to witness growth of $156 Bn By 2024

Similar presentations


Presentation on theme: "Cancer Diagnostics Market to witness growth of $156 Bn By 2024"— Presentation transcript:

1 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Cancer Diagnostics Market to witness growth of $156 Bn By 2024: Global Market Insights Inc.

2 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com  Cancer Diagnostics Market will exceed USD 150 billion by 2024; as per a new research report by Global Market Insights, Inc.  Increasing incidences of cancer across the globe will boost the global cancer diagnostics market over the forecast timeframe.  Cancer diagnosis is cost intensive hence developed economies such as U.S. and developing economies such as India are struggling to cope with rapidly increasing financial burden of the disease.  Advance fluid biopsy techniques, real time cancer diagnostics, increasing automation enabling faster test results will allow early and precise diagnosis of the condition.  Imaging segment currently dominates the industry and trend is anticipated to continue over forecast timeframe.  Advent of sophisticated imaging technologies such as positron emission tomography, that provides better quality results with low side effects will drive segment growth. Key Insights from Cancer Diagnostics Market:

3 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com  Lung-liver cancer accounted for largest market share due to high and rapidly increasing number of incidences.  Cancer research institutes, end user segment is predicted to grow at highest CAGR over the forecast period.  UK cancer diagnostics market is expected to witness significant growth over the forecast timeframe due to rapidly increasing cancer rates.  Increasing disposable income, healthcare infrastructure developments and growing accessibility to healthcare services will propel cancer diagnostics market growth in Asia Pacific region.  Some of the notable industry players are Abbott Laboratories, Alere, Becton, Dickinson and Company (BD), Biocartis, BioCare Medical, bioMérieux, Bio-Rad Laboratories, Cancer Genetics, GE Healthcare, Hologic, QIAGEN, Roche, Sysmex Corporation and Siemens Healthcare. Continued...

4 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com China Cancer Diagnostics Market, By Application, 2013 – 2024 (USD Million)

5 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Browse Full Market Research Report On Cancer Diagnostics Market @ http://bit.ly/2oJANND http://bit.ly/2oJANND Request for a Sample of this Research Report @ https://www.gminsights.com/request-sample/detail/2406 https://www.gminsights.com https://www.gminsights.com/request- sample/detail/49

6 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Stay In Touch Website: www.gminsights.comwww.gminsights.com Social Media:


Download ppt "Cancer Diagnostics Market to witness growth of $156 Bn By 2024"

Similar presentations


Ads by Google